Peptide purity explained

The short answer

For a synthetic peptide, purity usually means chromatographic purity: the percentage of the main peak measured by high performance liquid chromatography (HPLC), typically read at 220 nm. A separate measure, net peptide content, describes how much of the dry powder is actually peptide once bound water, counter-ions, and salts are accounted for. Identity is confirmed by mass spectrometry, which compares the observed molecular weight against the theoretical weight for the stated sequence. A Certificate of Analysis (COA) should report these values separately rather than collapsing them into one number.

What purity actually means

Purity sounds like a single idea, but for peptides it splits into at least two different questions. The first is how much of the peptide-related material in the sample is the target sequence rather than closely related by-products. The second is how much of the total dry weight in the vial is peptide at all, as opposed to water, salt, and counter-ions carried over from synthesis and purification. These are genuinely different measurements, and a high figure on one does not guarantee a high figure on the other.

In everyday vendor language, when a product is described as, say, 98% pure, that figure almost always refers to chromatographic purity by HPLC. It is a statement about relative composition of the peptide-related material, not about how much peptide sits in the powder by mass. Treating the two as the same thing is one of the most common misunderstandings when reading peptide documentation.

The two measures to keep separate

• Chromatographic purity: the share of the detected peptide material that is the target sequence, usually by HPLC
• Net peptide content: the fraction of the total dry powder that is peptide, after water, salt, and counter-ions are excluded

How HPLC measures chromatographic purity

Reverse phase high performance liquid chromatography (RP-HPLC) separates the components of a sample by pushing it through a column, where different molecules travel at different speeds and emerge at different times. As each component leaves the column it passes a UV detector. Peptides are commonly detected at around 220 nm, a wavelength where the peptide bond itself absorbs, which makes it a general detector for peptide-related material.

The output is a chromatogram: a trace with peaks, where each peak represents something that came off the column at a particular time. Chromatographic purity is then reported as the area of the main peak expressed as a percentage of the total peak area. A result of 98% means the main peak accounts for 98% of the detected area, with the remaining 2% spread across smaller peaks that represent impurities absorbing at that wavelength.

How mass spectrometry confirms identity

HPLC tells you how clean a sample is, but on its own it does not prove that the main peak is the peptide you intended to make. That is the job of mass spectrometry. The instrument ionises the sample and measures the mass-to-charge ratio of the resulting ions, which allows the molecular weight of the peptide to be determined and compared against the theoretical weight calculated from the stated sequence and molecular formula.

Electrospray ionisation mass spectrometry (ESI-MS) is a common choice, often paired with liquid chromatography so that separation and mass measurement happen in sequence. MALDI-TOF is another technique used for quick mass checks. In both cases the logic is the same: if the observed mass matches the theoretical mass within the expected tolerance, that supports the conclusion that the main peak is the intended peptide rather than a different molecule of similar retention time.

Reading HPLC and mass spectrometry together is the point. Purity without identity, or identity without purity, each leaves half the question open. A complete picture needs both: a clean chromatogram and a mass that matches the sequence.

Net peptide content, salt, and water

After RP-HPLC purification, a peptide is often isolated as a trifluoroacetic acid (TFA) salt, because TFA is widely used in the purification buffers. The counter-ion, along with non-covalently bound water, becomes part of the dry powder. Some workflows exchange the TFA salt for an acetate salt instead. Either way, the labelled weight of the powder overstates the mass of peptide actually present, because a portion of that weight is salt and water rather than peptide.

Net peptide content expresses the peptide as a percentage of total dry weight, and it is typically determined by techniques such as amino acid analysis (AAA) or nitrogen-based methods. It is entirely normal for a peptide to show very high HPLC purity while net peptide content sits well below the label weight, because the two measures are answering different questions. Vendor education pages commonly cite net peptide content figures in the region of 70 to 90% for salt-form powders, though the exact value depends on the peptide and the salt form and should be read from the actual COA rather than assumed.

Common impurities from peptide synthesis

Most research peptides are made by solid phase peptide synthesis (SPPS), where amino acids are added one at a time to a growing chain anchored to a resin. Because each step is a chemical reaction that is rarely perfect, characteristic by-products appear. These are what the smaller peaks on a chromatogram usually represent, and knowing the categories helps make sense of a COA.

Typical synthesis-related impurities

• Deletion sequences: a chain missing one internal residue, often linked to incomplete coupling or deprotection
• Truncated sequences: chains that stopped growing short of the full length
• Incomplete deprotection: residual protecting groups left on the finished chain
• Oxidation products: oxidation of sensitive residues such as methionine, cysteine, or tryptophan
• Acetylation and other capping or side-reaction products introduced during synthesis

Some of these are easier to separate than others. A deletion sequence missing a small residue such as glycine or alanine differs only slightly in mass and behaviour from the target, which can make it harder to resolve by HPLC alone. This is another reason identity confirmation by mass spectrometry is valuable alongside the purity figure, rather than relying on either measurement on its own.

What a Certificate of Analysis reports

A Certificate of Analysis (COA) is the document that brings these measurements together for a specific batch. A thorough COA does not just state a single purity number. It presents the analytical evidence so that the figure can be understood in context, and it ties that evidence to a particular lot rather than to the product line in general.

What a complete COA commonly includes

• Chromatographic purity as a percentage, usually by HPLC, with the chromatogram shown
• Mass spectrometry confirmation: observed molecular weight against the theoretical value
• The peptide sequence and molecular formula
• Net peptide content, where determined, reported separately from HPLC purity
• Physical appearance of the material, for example a white to off-white powder
• Water or moisture content, where measured
• Batch or lot identifier and the salt form

A figure of 98% or higher by HPLC is frequently cited as a benchmark for research-grade peptides, but it is best read as a commonly quoted reference point rather than a guarantee of anything in a given vial. The meaningful check is always the actual batch COA: the real chromatogram, the matching mass, and the stated net peptide content for the lot you are looking at.

Purity and identity are two questions, not one. A clean HPLC trace tells you how pure, and a matching mass tells you of what.

Purity is not sterility or endotoxin testing

It is worth being clear about what purity does not cover. Chromatographic purity, identity, and net peptide content are chemical measurements. They say nothing about whether a material is sterile, nor about whether it is free of bacterial endotoxins or other pyrogens. Sterility and endotoxin or pyrogen testing are separate analyses with their own methods, and a high purity figure should never be read as implying any of them.

How NovaPeptides documents purity

NovaPeptides supplies peptides strictly for laboratory research use only, never for human use. Products are accompanied by a third-party Certificate of Analysis so that the purity and identity figures can be checked against the underlying evidence rather than taken on trust. We do not make therapeutic claims and do not provide dosing information.

How the documentation works

• Supplied strictly for laboratory research use only, not for human or veterinary use
• Batch Certificate of Analysis available, reporting HPLC purity and mass spectrometry identity
• Sequence, molecular formula, and salt form stated for the material
• Research enquiries handled directly, with the COA available on request

The aim is simple: give researchers the numbers that actually matter and the document behind them. Purity by HPLC, identity by mass spectrometry, and net peptide content where reported, each read for what it is, on a per-batch basis.

Frequently asked questions